ALDH3A1 acts as a prognostic biomarker and inhibits the epithelial–mesenchymal transition of oral squamous cell carcinoma through IL-6/STAT3 signaling pathway (Qu et al. 2020). Here, ALDH3A1 is linked to oral cavity squamous cell carcinoma.